Pradžia › Neurologinės ligos › New York
Neurologinės ligos klinikiniai tyrimai New York
8 tyrimai dėl Neurologinės ligos ieško dalyvių vietose New York.
Miestai New York
Oficialus tyrimo tekstas (anglų kalba)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, New York
Renkami dalyviai2 fazė
Amžius nuo 55 iki 90 · Visoms lytims · Atnaujinta 2026-09-30 · NCT06887192Product Surveillance Registry
- Albany
- Bay Shore
- Huntington
- ir dar 10
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-09-18 · NCT01524276A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #055, Amherst
- Vima Site #024, New York
- Vima Site #052, Patchogue
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-11 · NCT07804615A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, New York
- Clinical Site, Staten Island
- Clinical Site, The Bronx
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-01 · NCT07459647Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP)
- Icahn School of Medicine at Mount Sinai, New York
Renkami dalyviaiStebimasis tyrimas
7 Months – 15 Months · Visoms lytims · Atnaujinta 2026-08-31 · NCT06805695Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
- University of Rochester Center for Health and Technology (CHeT), Rochester
Renkami dalyviai
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-08-27 · NCT06993142INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study
- University of Buffalo Neurosurgery, Buffalo
- Mount Sinai Hospital, New York
Renkami dalyviai
Amžius 22 ir vyresni · Visoms lytims · Atnaujinta 2026-05-11 · NCT07543367Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Staten Island
Renkami dalyviai2 fazė
Amžius nuo 50 iki 85 · Visoms lytims · Atnaujinta 2026-02-02 · NCT07105709Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.